CollPlant Biotechnologies Ltd — Cash Flow (NASDAQ:CLGN) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Cash from operating activities 4.45 M2.5 M13.7 M2.76 M14.09 M — Cash from investing activities 519 K31.56 M28.92 M1.16 M539 K — Cash from financing activities 4.46 M38.76 M1.87 M1.11 M9 000 — Free cash flow 3.93 M912 K12.38 M1.81 M13.61 M —

Notizie

CollPlant ottiene brevetto coreano per tecnologia di filler dermico

CollPlant secures Korean patent for dermal filler technology

CollPlant lancia il kit di bioinchiostro BioFlex per la biostampa 3D

CollPlant launches BioFlex bioink kit for 3D bioprinting

Opko Health: rating "Buy" confermato da H.C. Wainwright

Rating di CollPlant declassato a Hold da Buy da D. Boral Capital

CollPlant stock rating downgraded to Hold from Buy by D. Boral Capital

CollPlant Biotechnologies programma l’assemblea annuale e straordinaria per il 31 dicembre

CollPlant Biotechnologies schedules annual and extraordinary meeting for December 31

Gli EPS di Collplant ADR hanno mancato le aspettative per 0,41$, il fatturato appena sotto le previsioni

Collplant ADR earnings missed by $0.41, revenue fell short of estimates

Le azioni di CollPlant in calo mentre i ricavi del Q3 non raggiungono le stime